Similarities and differences between alpha-tocopherol and gamma-tocopherol in amelioration of inflammation, oxidative stress and pre-fibrosis in hyperglycemia induced acute kidney inflammation

키워드

참고문헌 (60)

1. Beulens JW, "The role of menaquinones (vitamin K2) in human health", Br J Nutr, 110, pp.1357~1368 (2013)
2. Kanwar YS, "Diabetic nephropathy: mechanisms of renal disease progression", Exp Biol Med (Maywood), 233, pp.4~11 (2008)
3. Tan AL, "AGE, RAGE, and ROS in diabetic nephropathy", Semin Nephrol, 27, pp.130~143 (2007)
4. Itoh K, "Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain", Genes Dev, 13, pp.76~86 (1999)
5. Forbes JM, "Oxidative stress as a major culprit in kidney disease in diabetes", Diabetes, 57, pp.1446~1454 (2008)
6. Geraldes P, "Activation of protein kinase C isoforms and its impact on diabetic complications", Circ Res, 106, pp.1319~1331 (2010)
7. Ma RC, "Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes", JAMA, 304, pp.881~889 (2010)
8. Border WA, "TGF-beta in kidney fibrosis: a target for gene therapy", Kidney Int, 51, pp.1388~1396 (1997)
9. Saijo K, "Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha", J Exp Med, 195, pp.1647~1652 (2002)
10. Sanz AB, "NF-kappaB in renal inflammation", J Am Soc Nephrol, 21, pp.1254~1262 (2010)
11. Barkett M, "Control of apoptosis by Rel", NF-kappaB transcription factors, 1999, pp.18, 6910~6924
12. Baeuerle PA, "Function and activation of NF-kappa B in the immune system", Annu Rev Immunol, 12, pp.141~179 (1994)
13. Ohga S, "Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation", Am J Physiol Renal Physiol, 292, pp.F1141~F1150 (2007)
14. Jangale NM, "Dietary flaxseed oil and fish oil modulates expression of antioxidant and inflammatory genes with alleviation of protein glycation status and inflammation in liver of streptozotocin-nicotinamide induced diabetic rats", Food Chem, 141, pp.187~195 (2013)
15. Gupta SK, "Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and antiinflammatory mechanisms", J Ocul Pharmacol Ther, 27, pp.123~130 (2011)
16. Kim MJ, "Protective effect of short-term genistein supplementation on the early stage in diabetes-induced renal damage", Mediators Inflamm, 2013, pp.510212~ (2013)
17. Sesso HD, "Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians'Health Study II randomized controlled trial", JAMA, 300, pp.2123~2133 (2008)
18. Shen XH, "Vitamin E regulates adipocytokine expression in a rat model of dietary-induced obesity", Exp Biol Med (Maywood), 235, pp.47~51 (2010)
19. Ju J, "Cancer-preventive activities of tocopherols and tocotrienols", Carcinogenesis, 31, pp.533~542 (2010)
20. Wu JH, "Effects of alpha-tocopherol and mixed tocopherol supplementation on markers of oxidative stress and inflammation in type 2 diabetes", Clin Chem, 53, pp.511~519 (2007)
21. Devaraj S, "Alpha-tocopherol decreases tumor necrosis factoralpha mRNA and protein from activated human monocytes by inhibition of 5-lipoxygenase", Free Radic Biol Med, 38, pp.1212~1220 (2005)
22. Devaraj S, "Alpha-tocopherol decreases interleukin-1 beta release from activated human monocytes by inhibition of 5-lipoxygenase", Arterioscler Thromb Vasc Biol, 19, pp.1125~1133 (1999)
23. Jiang Q, "gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention", Am J Clin Nutr, 74, pp.714~722 (2001)
24. Campbell S, "Development of gamma (gamma)-tocopherol as a colorectal cancer chemopreventive agent", Crit Rev Oncol Hematol, 47, pp.249~259 (2003)
25. Jiang Q, "Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats", FASEB J, 17, pp.816~822 (2003)
26. Park NY, "Short term supplementation of dietary antioxidants selectively regulates the inflammatory responses during early cutaneous wound healing in diabetic mice", Nutr Metab (Lond), 8, pp.80~ (2011)
27. Ohkawa H, "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction", Anal Biochem, 95, pp.351~358 (1979)
28. Lee R, "The Antioxidant Vitamins C and E. Champaign", pp.180~194 (2002), AOCS Press
29. Zhao Y, "Analysis of multiple metabolites of tocopherols and tocotrienols in mice and humans", J Agric Food Chem, 58, pp.4844~4852 (2010)
30. Ventura-Sobrevilla J, "Effect of varying dose and administration of streptozotocin on blood sugar in male CD1 mice", Proc West Pharmacol Soc, 54, pp.5~9 (2011)
31. Matteucci E, "Proposal open for discussion: defining agreed diagnostic procedures in experimental diabetes research", J Ethnopharmacol, 115, pp.163~172 (2008)
32. Kim SS, "Vitamin E and probucol reduce urinary lipophilic aldehydes and renal enlargement in streptozotocininduced diabetic rats", Lipids, 35, pp.1225~1237 (2000)
33. Hosten AO., "Clinical Methods: the History, Physical, and Laboratory Examinations", pp.874~878 (1990), Butterworths
34. Haidara MA, "Evaluation of the effect of oxidative stress and vitamin E supplementation on renal function in rats with streptozotocin-induced Type 1 diabetes", J Diabetes Complications, 23, pp.130~136 (2009)
35. Chang JM, "Increased glomerular and extracellular malondialdehyde levels in patients and rats with diabetic nephropathy", J Lab Clin Med, 146, pp.210~215 (2005)
36. Salahudeen AK, "Pathogenesis of diabetic nephropathy: a radical approach", Nephrol Dial Transplant, 12, pp.664~668 (1997)
37. Baydas G, "Comparative analysis of the protective effects of melatonin and vitamin E on streptozocininduced diabetes mellitus", J Pineal Res, 32, pp.225~230 (2002)
38. Tanaka Y, "Hepatic ischemiareperfusion induces renal heme oxygenase-1 via NF-E2-related factor 2 in rats and mice", Mol Pharmacol, 71, pp.817~825 (2007)
39. Negre-Salvayre A, "Hyperglycemia and glycation in diabetic complications", Antioxid Redox Signal, 11, pp.3071~3109 (2009)
40. Das J, "Taurine exerts hypoglycemic effect in alloxan-induced diabetic rats, improves insulin-mediated glucose transport signaling pathway in heart and ameliorates cardiac oxidative stress and apoptosis", Toxicol Appl Pharmacol, 258, pp.296~308 (2012)
41. Ribeiro G, "N-acetylcysteine on oxidative damage in diabetic rats", Drug Chem Toxicol, 34, pp.467~474 (2011)
42. Piwkowska A, "High glucose concentration affects the oxidant-antioxidant balance in cultured mouse podocytes", J Cell Biochem, 112, pp.1661~1672 (2011)
43. Yoo JH, "Vulnerability of the human airway epithelium to hyperoxia. Constitutive expression of the catalase gene in human bronchial epithelial cells despite oxidant stress", J Clin Invest, 93, pp.297~302 (1994)
44. Kobayashi M, "Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice", Kidney Int, 68, pp.1018~1031 (2005)
45. Baud O, "Glutathione peroxidase-catalase cooperativity is required for resistance to hydrogen peroxide by mature rat oligodendrocytes", J Neurosci, 24, pp.1531~1540 (2004)
46. Mohamed AK, "The role of oxidative stress and NF-kappaB activation in late diabetic complications", Biofactors, 10, pp.157~167 (1999)
47. Kolb M, "Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis", J Clin Invest, 107, pp.1529~1536 (2001)
48. Dinarello CA., "Interleukin-1", Cytokine Growth Factor Rev, 8, pp.253~265 (1997)
49. Navarro-González JF, "The role of inflammatory cytokines in diabetic nephropathy", J Am Soc Nephrol, 19, pp.433~442 (2008)
50. Barzilay JI, "The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study", Diabetes, 50, pp.2384~2389 (2001)
51. Eklund CM., "Proinflammatory cytokines in CRP baseline regulation", Adv Clin Chem, 48, pp.111~136 (2009)
52. Himmelfarb J, "Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease", Kidney Int, 64, pp.978~991 (2003)
53. Sharma K, "Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator", Diabetes, 44, pp.1139~1146 (1995)
54. Giacco F, "Oxidative stress and diabetic complications", Circ Res, 107, pp.1058~1070 (2010)
55. Brownlee M., "Biochemistry and molecular cell biology of diabetic complications", Nature, 414, pp.813~820 (2001)
56. Koya D, "Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats", J Clin Invest, 100, pp.115~126 (1997)
57. Meier M, "Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model", Diabetes, 56, pp.346~354 (2007)
58. Chen S, "Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up", Semin Nephrol, 23, pp.532~543 (2003)
59. Sharma K, "Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice", Diabetes, 45, pp.522~530 (1996)
60. Border WA, "Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy", Kidney Int, 54, pp.1390~1391 (1998)

관련 논문AI추천